The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Regional · UK & Ireland · continued

NHS criteria and how they are applied in practice posts 31–43

This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.

V
VThorvaldsenTL3Regular16 Jul 2026#31

I would keep NHS criteria and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging them is why the last one went badly.

0 likes 12d
IB
i.brobergTL217 Jul 2026#32
K
KnowltonTL3Regular17 Jul 2026#33

Small methodological point on NHS criteria: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.

18 likes 10d
EK
e.kimaniTL218 Jul 2026 · edited#34

Pharmacy practice varies between pharmacies and is not deducible from the regulatory position. Two people can honestly report opposite experiences.

On balance I think that is right, and I would not bet much on it.

0 likes 10d
PS
p.silvaTL219 Jul 2026#35
i.broberg, post #32: I read post #29 twice before replying, because I had assumed the opposite. Importing for personal use: importing a prescription-only medicine without a prescription is not lawful. Material sold as research-use-only is not a licensed medicine regardless of content. Go to post

Seconded. It reads as careful rather than confident, which is the right register.

0 likes in reply to #32 9d
AA
a.almeidaTL220 Jul 2026#36
eire_reader, post #6: NHS criteria came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction. Go to post

Coming back to post #33, because the follow-up matters more than the original answer.

MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and private prescribing routes exist with materially different access criteria and costs.

I have written this out at length because the short version keeps being misread.

2 likes in reply to #6 8d
AW
a.weissTL221 Jul 2026#37

Regional variation in NHS: access varies dramatically by region depending on local commissioning decisions and specialist service availability. Postcode determines access risk.

Two people can read the same figure differently here and both be reasonable.

12 likes 7d
KR
k.roosTL222 Jul 2026#38

Trying to state the NHS criteria position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread passes that test.

26 likes 6d
LD
l.dziedzicTL223 Jul 2026 · edited#39

NHS access has been restricted by commissioning criteria, not by licensing. Specialist weight-management services in many areas require prior weight-loss attempts, BMI thresholds, or other specific criteria.

Genuinely open to being wrong about this one.

0 likes 5d
NL
n.lehtinenTL224 Jul 2026#40

The thing about NHS criteria that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.

0 likes 4d
BW
bac_waterTL2Regular25 Jul 2026#41

Everything in post #37 holds. The case it does not cover is the one I have.

The most useful contribution is a link to the current official page with the date you accessed it. That survives; a paraphrase does not.

Worth one more sentence than it usually gets.

0 likes 3d
IB
i.boatengTL225 Jul 2026#42

Small correction to my own earlier position on NHS criteria. I had the units the wrong way round, which changes the conclusion by an order of magnitude and therefore changes it entirely.

27 likes 2d
OF
outline_firstTL3Wiki editor26 Jul 2026#43
ai.vukovic, post #5: NHS access has been restricted by commissioning criteria, not by licensing. Specialist weight-management services in many areas require prior weight-loss attempts, BMI thresholds, or other specific criteria. Worth reading the earlier posts in this thread before acting on mine. Go to post

On NHS criteria: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any reply here including this one.

13 likes in reply to #5 2d
Promoted into the documentation commons. The content of this topic is maintained at Access notes: Ireland, with named maintainers and a review date. The promotion was discussed in doc review. Corrections are best raised against the document, which is the version that gets kept current.

Suggested topics

TopicParticipantsRepliesViewsActivity
Second pass at: Pharmacy supply in the UK and the questions you will be asked
Second pass at: Pharmacy supply in the UK and the questions you will be asked Writing it up because I had to work it out twice and would rather nobody else did. Asking about Pharmacy supply on behalf of the…
DBDATFHKD+46 53 14k 12mo
About the UK & Ireland category
MHRA positions, NHS pathways, private prescriptions, and Irish differences. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author and a…
SLHSJVIAK+3 7 357 3mo
UK access routes, dated and sourced
UK access routes, dated and sourced Writing it up because I had to work it out twice and would rather nobody else did. Regional question, dated June 2026, because everything in this category expires. The…
NROJC 2 5.8k 15mo
Pharmacy supply in the UK and the questions you will be asked
On the subject in the title: Pharmacy supply in the UK and the questions you will be asked Working notes rather than a conclusion. Asking about pharmacy supply on behalf of the question I keep seeing asked…
CMCBRMNSP+95 105 1.3k 4mo
MHRA statements, read directly — the long version
On the subject in the title: MHRA statements, read directly — the long version Working notes rather than a conclusion. Asking about MHRA statements directly, because I have read four threads on it and each…
BRTDSL 2 44k 22mo

Related topics — sharing the tags NHS, cost per milligram, personal import

TopicParticipantsRepliesViewsActivity
EU-wide position versus national implementation
EU-wide position versus national implementation Writing it up because I had to work it out twice and would rather nobody else did. Eu-wide position versus national implementation: what I expected, what I…
BBCLSGLEVK+22 29 356 11mo
Revisiting: Language barriers in accessing a prescription abroad
Posting this under the heading it deserves: Revisiting: Language barriers in accessing a prescription abroad Everything below is what sits behind that. Asking about Language barriers in accessing on behalf of…
MMLSSLMIMH+131 148 28k 5mo
Personal import allowances, compared
On the subject in the title: Personal import allowances, compared Working notes rather than a conclusion. I have spent a fortnight trying to pin personal import allowances down and I want to set out where I…
BANNKAKSC+5 9 3.2k 7mo
Travelling with an injectable: documentation and practicalities
Posting this under the heading it deserves: Travelling with an injectable: documentation and practicalities Everything below is what sits behind that. Documenting a stated criterion rather than an outcome,…
CHATJSFEB+37 42 2.1k 1d
Price changes over 2025 and 2026, tabulated and dated — does this still hold?
Price changes over 2025 and 2026, tabulated and dated — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Documenting an access outcome, dated,…
WMCCDFKSDO+147 156 18k 3mo